|

The Challenges of Treating Mesothelioma in the Heart

The Challenges of Treating Mesothelioma in the Heart

Researchers from Sahloul Hospital in Tunisia shared the case of a 44-year-old woman with a very rare diagnosis of sarcomatous mesothelioma of the heart.

A Rare Diagnosis with Dire Consequences

Mesothelioma is an aggressive cancer that grows in the lining of the lungs and abdominal cavity. In rare instances, it can also develop in other areas like the heart. It is caused by exposure to asbestos, which is a toxic mineral.

Mesothelioma in the heart only occurs in less than 0.7% of all mesothelioma cases. The symptoms usually look like other, more common, heart conditions. People with mesothelioma in their hearts might feel heart palpitations, shortness of breath, fatigue, and chest pains.

Since the heart is such a delicate and important organ, the treatment options are limited, and the prognosis is poor.

Because mesothelioma in the heart is so rare, cases like this one are important for learning more about how to treat this disease.

Understanding Mesothelioma’s Impact on This Vital Organ

In this case, the woman went to the hospital because she was having trouble breathing, experiencing heart palpitations, and fainting. Tests showed a tumor in her heart, which was causing problems with her heart valves and function.

The doctors performed urgent surgery to remove the tumor and repair the affected heart valves. Unfortunately, the tumor came back later, and the patient did not survive.

This case is important because mesothelioma in the heart is very rare, and there have been only a few cases reported in medical literature. This case suggests that when a patient has a large tumor in their heart, quick surgery might be needed to prevent serious problems.

However, completely removing the tumor may not always be possible. In some cases, less invasive surgery or other treatments might be used to relieve symptoms and improve the patient’s quality of life. Overall, the prognosis for this condition is not good, and more research is needed to find effective treatments.

Source

Rouabeh W, Cherif T, Mgarrech I, Ajmi N, Kortas C, Jerbi S. Case report and analysis of the literature on sarcomatous mesothelioma of the left atrium [published online ahead of print, 2023 Jul 21]. Int J Surg Case Rep. 2023;109:108537. doi:10.1016/j.ijscr.2023.108537. https://pubmed.ncbi.nlm.nih.gov/37517251/

Similar Posts

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Victims’ Victory in Pennsylvania

    Workers and their families have won a victory in Pennsylvania after the state Supreme Court ruled that they could sue former employers over late-manifesting industrial diseases like mesothelioma. The decision focused on a provision in Pennsylvania’s Workers’ Compensation Act that says workers cannot sue an employer if their occupational disease occurred more than 300 weeks after their on-the-job exposure. While many occupational injuries and diseases occur within weeks or months of exposure to a toxin, asbestos diseases like mesothelioma are a notable exception. Believed to be caused by chronic irritation from inhaled or ingested asbestos fibers, mesothelioma does not usually begin to cause symptoms until at least a decade after exposure. Expressing the opinion of the majority, Supreme Court Justice…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…